SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,913 | +387.3% | 827,577 | +334.8% | 0.13% | +362.1% |
| Q1 2023 | $7,986 | -100.0% | 190,333 | -14.3% | 0.03% | -72.6% |
| Q3 2019 | $31,144,000 | -64.5% | 221,994 | -53.6% | 0.11% | -62.8% |
| Q2 2019 | $87,629,000 | -11.2% | 478,611 | -22.9% | 0.28% | -13.4% |
| Q1 2019 | $98,717,000 | +706.6% | 620,668 | +385.8% | 0.33% | +631.1% |
| Q4 2018 | $12,238,000 | -71.2% | 127,758 | -57.5% | 0.04% | -61.9% |
| Q3 2018 | $42,455,000 | -49.9% | 300,565 | -44.4% | 0.12% | -52.2% |
| Q2 2018 | $84,664,000 | +12.4% | 540,878 | +15.6% | 0.25% | +10.3% |
| Q1 2018 | $75,357,000 | -31.9% | 467,854 | -30.3% | 0.22% | -28.9% |
| Q4 2017 | $110,609,000 | +544.0% | 671,535 | +143.6% | 0.32% | +530.0% |
| Q3 2017 | $17,174,000 | -40.4% | 275,665 | -23.8% | 0.05% | -41.9% |
| Q2 2017 | $28,805,000 | -41.6% | 361,688 | -47.9% | 0.09% | -41.9% |
| Q1 2017 | $49,359,000 | +68.7% | 694,506 | +21.2% | 0.15% | +66.3% |
| Q4 2016 | $29,260,000 | -6.4% | 573,054 | -15.6% | 0.09% | -6.3% |
| Q3 2016 | $31,270,000 | +43.6% | 679,048 | -6.1% | 0.10% | +39.7% |
| Q2 2016 | $21,778,000 | +27.8% | 722,800 | +36.0% | 0.07% | +25.9% |
| Q1 2016 | $17,037,000 | -73.3% | 531,404 | -51.5% | 0.05% | -71.9% |
| Q4 2015 | $63,855,000 | +479.5% | 1,095,283 | +320.7% | 0.19% | +481.8% |
| Q3 2015 | $11,019,000 | -86.1% | 260,368 | -76.0% | 0.03% | -84.2% |
| Q2 2015 | $79,359,000 | +778.3% | 1,087,109 | +504.3% | 0.21% | +808.7% |
| Q1 2015 | $9,036,000 | +128.1% | 179,897 | +66.2% | 0.02% | +130.0% |
| Q4 2014 | $3,961,000 | – | 108,226 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |